These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8665618)

  • 1. Spectral shape modifications of anthracyclines bound to cell nuclei: a microspectrofluorometric study.
    Laigle A; Fiallo MM; Garnier-Suillerot A
    Chem Biol Interact; 1996 Jun; 101(1):49-58. PubMed ID: 8665618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei.
    Frezard F; Garnier-Suillerot A
    Biochim Biophys Acta; 1990 Nov; 1036(2):121-7. PubMed ID: 2223830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of iron-anthracycline complexes with living cells: a microspectrofluorometric study.
    Fiallo M; Laigle A; Garnier-Suillerot A; Amirand C; Ballini JP; Chinsky L; Duquesne M; Jolles B; Sureau F; Turpin PY
    Biochim Biophys Acta; 1993 Jun; 1177(3):236-44. PubMed ID: 8323977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells.
    Fiallo M; Laigle A; Borrel MN; Garnier-Suillerot A
    Biochem Pharmacol; 1993 Feb; 45(3):659-65. PubMed ID: 8095138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daunorubicin and doxorubicin molecular interplay with 2D membrane models.
    Alves AC; Nunes C; Lima J; Reis S
    Colloids Surf B Biointerfaces; 2017 Dec; 160():610-618. PubMed ID: 29028609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding.
    Gieseler F; Biersack H; Brieden T; Manderscheid J; Nüssler V
    Ann Hematol; 1994; 69 Suppl 1():S13-7. PubMed ID: 8061108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.
    Seeber S; Loth H; Crooke ST
    J Cancer Res Clin Oncol; 1980; 98(2):109-18. PubMed ID: 6938517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxidase- and nitrite-dependent metabolism of the anthracycline anticancer agents daunorubicin and doxorubicin.
    Reszka KJ; McCormick ML; Britigan BE
    Biochemistry; 2001 Dec; 40(50):15349-61. PubMed ID: 11735418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation.
    Hovorka O; Subr V; Větvička D; Kovář L; Strohalm J; Strohalm M; Benda A; Hof M; Ulbrich K; Ríhová B
    Eur J Pharm Biopharm; 2010 Nov; 76(3):514-24. PubMed ID: 20638475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser flow cytometric studies on the intracellular fluorescence of anthracyclines.
    Krishan A; Ganapathi R
    Cancer Res; 1980 Nov; 40(11):3895-900. PubMed ID: 6937236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the fluorescence signature of daunomycin and doxorubicin.
    Karukstis KK; Thompson EH; Whiles JA; Rosenfeld RJ
    Biophys Chem; 1998 Jul; 73(3):249-63. PubMed ID: 9700924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular pharmacology of detorubicin and doxorubicin in L1210 cells.
    Zenebergh A; Baurain R; Trouet A
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):115-21. PubMed ID: 6537910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs.
    Jollès B; Laigle A; Priebe W; Garnier-Suillerot A
    Chem Biol Interact; 1996 Mar; 100(2):165-76. PubMed ID: 8646789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopic studies of anthracyclines: Structural characterization and in vitro tracking.
    Szafraniec E; Majzner K; Farhane Z; Byrne HJ; Lukawska M; Oszczapowicz I; Chlopicki S; Baranska M
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Dec; 169():152-60. PubMed ID: 27372511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake kinetics and intracellular distribution of anthracyclines studied by laser cytofluorometry.
    Prosperi E; Croce AC; Bottiroli G; Dasdia T; Supino R
    Basic Appl Histochem; 1983; 27(2):117-27. PubMed ID: 6577857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1997 Apr; 40(8):1276-86. PubMed ID: 9111302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r].
    Hu X; Chen WY
    Zhongguo Yao Li Xue Bao; 1994 May; 15(3):275-9. PubMed ID: 7976387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of the cyano moiety in the crystal structure of N-cyanomethyl-N-(2-methoxyethyl)-daunomycin complexed with d(CGATCG).
    Saminadin P; Dautant A; Mondon M; Langlois D'estaintot B; Courseille C; Précigoux G
    Eur J Biochem; 2000 Jan; 267(2):457-64. PubMed ID: 10632715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives.
    Frezard F; Garnier-Suillerot A
    Biochemistry; 1991 May; 30(20):5038-43. PubMed ID: 2036371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence specificity in the binding of anti-tumour anthracyclines to DNA: a success of theory.
    Pullman B
    Anticancer Drug Des; 1991 May; 6(2):95-105. PubMed ID: 2039585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.